文献速递神经肿瘤功能神经外科

成人胶质瘤患者的工作记忆训练:一项概念验证研究

Working memory training for adult glioma patients: a proof-of-concept study.
PubMed 文献 · J Neurooncol · 2021-09-07

本研究纳入20例存在客观和/或主观工作记忆缺陷的成人胶质瘤患者,评估CogMed工作记忆训练(CWMT)的安全性、可行性与满意度。16例完成干预(保留率80%),无研究相关不良事件,依从性69%,感知获益仅中等,但神经认知任务显示中到大效应量,心理症状稳定。

要点

  • CWMT在成人胶质瘤患者中安全可接受,保留率80%、依从性69%。
  • 客观工作记忆改善达中到大效应量,但患者感知获益仅中等。
  • 时间负担与训练强度可能影响感知获益与依从性。

核心结论

  • CWMT在成人胶质瘤患者中安全且可接受,入组、保留率与治疗依从性均充足。
  • 尽管客观工作记忆改善,患者感知获益仅中等,可能与时间投入和干预强度有关。

研究设计与样本

  • 单臂概念验证研究,纳入20例有客观和/或感知工作记忆缺陷的成人胶质瘤患者。
  • 52%为高级别胶质瘤,60%为女性,平均年龄47岁(范围21-72岁)。
  • 干预为CogMed工作记忆训练,5周内每周5天、每天50分钟训练。
  • 试验注册号NCT03323450,注册日期2017年10月27日。

主要发现

  • 20例入组患者中16例完成干预,保留率80%。
  • 退出原因包括时间负担(n=2)、肿瘤相关疲劳(n=1)和失访(n=1)。
  • 未发现与研究相关的不良事件。
  • 依从性为69%,不依从原因与退出原因相似。
  • 感知获益程度仅为中等。

临床怎么用

  • CWMT可作为成人胶质瘤工作记忆缺陷患者的可行干预选项,需关注时间负担与疲劳对依从性的影响。
  • 临床应结合客观认知评估与患者感知获益,优化训练强度以提高接受度。

局限性

  • 样本量小(20例),为非对照概念验证研究。
  • 感知获益仅中等,训练强度可能影响结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: CogMed Working Memory Training (CWMT) is a computer-based program shown to improve working memory (WM) among those with cognitive impairments. No study to date has investigated its feasibility, acceptability, and satisfaction in adult patients with glioma, despite the well-documented incidence of WM impairment in this population. METHODS: Twenty patients with glioma and objective and/or perceived WM deficits enrolled in the study: 52% high-grade, 60% female, Mage = 47 (range = 21-72 years). Adverse events were monitored to determine safety. Feasibility and acceptability were assessed based on established metrics. Satisfaction was explored by exit-interviews. Neurocognitive tests and psychological symptoms were analyzed at baseline and post-CWMT to estimate effect sizes. RESULTS: Of 20 enrolled patients, 16 completed the intervention (80% retention rate). Reasons for withdrawal included time burden (n = 2); tumor-related fatigue (n = 1) or loss to follow-up (n = 1). No adverse events were determined to be study-related. Adherence was 69% with reasons for nonadherence similar to those for study withdrawal. The perceived degree of benefit was only moderate. Baseline to post-CWMT assessments showed medium to large effects on neurocognitive tasks. Psychological symptoms remained stable throughout the study period. CONCLUSIONS: CWMT was found to be safe and acceptable in adult patients with glioma. Enrollment, retention rates, and treatment adherence were all adequate and comparable to studies recruiting similar populations. Only moderate perceived benefit was reported despite demonstrated improvements in objectively-assessed WM. This may indicate that the time commitment and intervention intensity (5 weeks of 50-min training sessions on 5 days/week) outweighed the perceived benefits of the program. (Trial Registration Number: NCT03323450 registered on 10/27/2017).

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Braun SE, Aslanzadeh FJ, Lanoye A, et al. Working memory training for adult glioma patients: a proof-of-concept study. J Neurooncol. 2021. PMID: 34491526. doi:10.1007/s11060-021-03839-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。